Clinical study on the application of pressing acupuncture and umbilical therapy under the concept of ERAS in the recovery after laparoscopic radical gastric cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049062

Enrollment

Unknown

Registered

2021-07-20

Start date

2022-04-01

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recovery after gastric cancer

Interventions

Laparoscopic ERAS + Press Needle Therapy Group :Laparoscopic radical gastric cancer surgery, perioperative period in accordance with the ERAS concept, and postoperative needle acupuncture therapy

Laparoscopic ERAS + Shenque Point Application Therapy Group :Laparoscopic radical gastric cancer surgery, perioperative period in accordance with the ERAS concept, after the operation, Shenque acupoin

Laparoscopic ERAS + Press Needle Therapy + Shenque Point Application Therapy Group :Laparoscopic radical resection of gastric cancer. Follow the concept of ERAS during the perioperative period, follow

Simple Laparoscopy ERAS Concept Management Group:Laparoscopic radical resection of gastric cancer, according to the ERAS concept during the perioperative period

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Histopathology is clearly diagnosed as gastric cancer; 2. cTNM staging is in cT2~4aN0~3M0 (the 8th edition of UICC staging standard in 2016); 3. No serious heart, lung, liver, kidney, brain or systemic immune diseases Those; 4. Laparoscopic radical gastric cancer resection can remove the tumor in the treatment intention; 5. The patients informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with severe cognitive impairment; 2. The skin of the acupuncture point and Shenque point is infected or damaged; 3. Patients with incomplete clinical data, falling off of needles and applicators, allergic constitution or needle fainting.

Design outcomes

Primary

Measure	Time frame
First exhaust time after operation;Time of first bowel movement after surgery;Time of first fluid intake after operation;Time to get out of bed for the first time after surgery;Postoperative hospital stay;Blood routine;Kidney function;liver function;Electrolyte;C reactive protein;IL-6;procalcitonin;Tumor necrosis factor-a;	—

Countries

China

Contacts

Public ContactWang Qian

Affiliated Hospital of Guizhou Medical University

wangqian5969@163.com+86 15885004333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026